https://health.economictimes.indiatimes.com/news/industry/study-finds-how-novel-immunotherapy-helps-fight-against-high-risk-prostate-cancers/99341147
0
0
4/8/23 at 12:00pm
Organization
The Times of India
Author
ET HealthWorld
36 words
0
Comments
Enoblituzumab has the potential to be the first effective antibody-based immunotherapy treatment for prostate cancer if results from subsequent studies are positive.
6 similar articles
You are the first to view
Create an account
or login to join the discussion